Julie C. Harper, MD: Acne Advocacy
Dr. Harper discusses her AAD 2022 presentation on acne advocacy, which entails not only advocating for her patients with acne, but also advocating for the disease state by highlighting gaps in current acne treatment guidelines.
John Barbieri, MD, MBA: Managing Isotretinoin Side Effects
Dr. Barbieri recaps his presentation from the acne symposium at AAD 2022, in which he provided guidance on managing patient labs and discussed adjuvant therapies to reduce mucocutaneous dryness and initial acne flares in patients being treated with isotretinoin.
John E. Harris, MD, PhD: Developments in Vitiligo
Dr. Harris provides an overview of the most exciting topics he discussed during his several presentations delivered at AAD 2022.
Peter Lio, MD: Food and Dietary Changes in Atopic Dermatitis
Dr. Lio reviews his AAD presentation, which focused on disentangling the mythology around nutrition and atopic dermatitis and how to talk with patients about this topic.
Journal Review: Linda Stein Gold
Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, “Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.”